Tilray Stock Continues To Climb After Earnings Beat, Record Revenue

4/2/2026
Impact: 85
Healthcare

Tilray Brands Inc (NASDAQ: TLRY) reported fiscal third-quarter adjusted earnings of 2 cents per share, surpassing analyst expectations for a loss of 14 cents, with revenue of $206.7 million, exceeding the $201.35 million consensus and reflecting an 11.3% year-over-year increase. Cannabis revenue rose 19% to $64.8 million, driven by a 73% increase in international cannabis revenue. The company ended the quarter with $264.8 million in cash and marketable securities, while Roth Capital upgraded its stock rating from Neutral to Buy, maintaining a $10 price target.

AI summary, not financial advice

Share: